Serina Therapeutics, Inc.
SER
$1.56
-$0.07-4.29%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.24% | 28.89% | -33.97% | -75.66% | -294.33% |
| Total Depreciation and Amortization | 50.00% | 0.00% | -5.88% | -69.64% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00% |
| Total Other Non-Cash Items | -149.93% | -134.26% | 10,300.00% | 101.09% | 68.59% |
| Change in Net Operating Assets | -177.87% | 97.73% | 55.16% | 364.53% | -115.55% |
| Cash from Operations | -56.70% | -2.67% | 13.23% | 5.82% | -54.93% |
| Capital Expenditure | 100.00% | 71.74% | -- | -- | -66.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 71.74% | -- | -- | -66.67% |
| Total Debt Issued | -100.00% | -- | -- | -- | 1,275.00% |
| Total Debt Repaid | -- | -- | -- | -- | 87.50% |
| Issuance of Common Stock | 252.51% | 143.02% | 62,900.00% | -99.98% | 5,623.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -92.54% | 15.69% | 13.28% | -2.27% | 5,750.00% |
| Foreign Exchange rate Adjustments | -500.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -315.74% | 45.38% | 198.15% | 36.16% | 115.18% |